================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 2, 2003
THE COOPER COMPANIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 1-8597 94-2657368
(State or other jurisdiction (Commission File Number) (IRS Employer Identification No.)
of incorporation)
6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588
(Address of principal executive offices)
(925) 460-3600 (Registrant's
telephone number, including area code)
================================================================================
ITEM 5. Other Events.
On December 2, 2003, The Cooper Companies, Inc. issued a press release
announcing that CooperSurgical, its women's healthcare unit, had completed the
acquisition of the assets and associated worldwide license rights of certain
product lines from SURx, Inc. A copy of this release is attached and
incorporated by reference.
Internet addresses in the release are for information purposes only and are not
intended to be hyperlinks to other Cooper Companies information.
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit
No. Description
------- -----------
99.1 Press Release dated December 2, 2003 of The Cooper Companies, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
THE COOPER COMPANIES, INC.
By /s/ Stephen C. Whiteford
--------------------------------
Stephen C. Whiteford
Vice President and
Corporate Controller
(Principal Accounting Officer)
Dated: December 4, 2003
EXHIBIT INDEX
Exhibit Sequentially
No. Description Numbered Page
------- ----------- -------------
99.1 Press Release dated December 2, 2003 of The Cooper
Companies, Inc.
STATEMENT OF DIFFERENCES
The trademark symbol shall be expressed as............................... 'TM'
The registered trademark symbol shall be expressed as.................... 'r'